<code id='C08517E0C0'></code><style id='C08517E0C0'></style>
    • <acronym id='C08517E0C0'></acronym>
      <center id='C08517E0C0'><center id='C08517E0C0'><tfoot id='C08517E0C0'></tfoot></center><abbr id='C08517E0C0'><dir id='C08517E0C0'><tfoot id='C08517E0C0'></tfoot><noframes id='C08517E0C0'>

    • <optgroup id='C08517E0C0'><strike id='C08517E0C0'><sup id='C08517E0C0'></sup></strike><code id='C08517E0C0'></code></optgroup>
        1. <b id='C08517E0C0'><label id='C08517E0C0'><select id='C08517E0C0'><dt id='C08517E0C0'><span id='C08517E0C0'></span></dt></select></label></b><u id='C08517E0C0'></u>
          <i id='C08517E0C0'><strike id='C08517E0C0'><tt id='C08517E0C0'><pre id='C08517E0C0'></pre></tt></strike></i>

          Home / fashion / hotspot

          hotspot


          hotspot

          author:Wikipedia    Page View:483
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In